← National Association of Chain Drug Stores
FDANonrulemakingFDA-2016-D-1309

Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act; Draft Guidance for Industry; Availability

RIN
—
Last modified
Oct 21, 2019
Comment window
closed 3080d ago
National Association of Chain Drug Stores filings
1

Activity

National Association of Chain Drug Stores filed 1 comment on this docket between Oct 12, 2016 and Oct 12, 2016. 10 other organizations filed here. The comment window closed 3080d ago.

What National Association of Chain Drug Stores filed (1)

Oct 12, 2016· Comment from National Association of Chain Drug Stores (NACDS)· FDA-2016-D-1309-0058

Please see the attached comments of the National Association of Chain Drug Stores (NACDS) on the FDA draft guidance on "Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act". We appreciate the opportunity to provide input to FDA on this matter.

View on regulations.gov →

Abstract

No abstract recorded.

View on regulations.gov →

Co-filers (10)

See everyone who commented →